Abstract
The concept of providing psychophar-macological treatment for children and youth remains controversial. This has especially been true regarding the use of monoamine oxidase inhibitors (MAOIs) due to their significant side effects and concern about dietary adherence by children, youth, and their families. However, some literature and clinical experience exists on their use in common pediatric Psychiatric disorders. This article reviews this literature and a case series in the context of these concerns and raises questions about the reconsideration of these agents in the pediatric population.
| Original language | American English |
|---|---|
| Pages (from-to) | 507-512 |
| Number of pages | 6 |
| Journal | Psychiatric Annals |
| Volume | 44 |
| Issue number | 11 |
| DOIs | |
| State | Published - 2014 |
ASJC Scopus subject areas
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'Revisiting the role of monoamine oxidase inhibitors in pediatric psychopharmacology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver